Scott Heller

912 total citations
8 papers, 648 citations indexed

About

Scott Heller is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Scott Heller has authored 8 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Scott Heller's work include Amyotrophic Lateral Sclerosis Research (4 papers), Cancer therapeutics and mechanisms (2 papers) and Neurogenetic and Muscular Disorders Research (2 papers). Scott Heller is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (4 papers), Cancer therapeutics and mechanisms (2 papers) and Neurogenetic and Muscular Disorders Research (2 papers). Scott Heller collaborates with scholars based in United States and France. Scott Heller's co-authors include Senda Ajroud‐Driss, Teepu Siddique, Robert Sufit, Françoise Garrouste, Frederic André, Jacques Marvaldi, Nailah Siddique, G. Pommier, M Remacle-Bonnet and Hong Zhai and has published in prestigious journals such as Annals of Neurology, Molecular Cancer Therapeutics and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Scott Heller

8 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Heller United States 8 313 285 270 71 56 8 648
F. Ajmar Italy 17 163 0.5× 189 0.7× 253 0.9× 24 0.3× 209 3.7× 56 748
Michał Rynkowski Poland 13 387 1.2× 68 0.2× 232 0.9× 37 0.5× 11 0.2× 34 809
Luc Régal Belgium 15 119 0.4× 74 0.3× 336 1.2× 36 0.5× 15 0.3× 33 689
A. Pozzi Italy 11 101 0.3× 134 0.5× 58 0.2× 112 1.6× 28 0.5× 19 389
Elisa Lupino Italy 11 191 0.6× 106 0.4× 254 0.9× 31 0.4× 7 0.1× 14 465
Barbara Buccinnà Italy 9 191 0.6× 106 0.4× 254 0.9× 34 0.5× 7 0.1× 14 485
Elisa Fassone Italy 13 132 0.4× 70 0.2× 705 2.6× 12 0.2× 7 0.1× 19 880
Marija Tadin‐Strapps United States 14 76 0.2× 29 0.1× 255 0.9× 21 0.3× 25 0.4× 19 596
Sima Kheradmand Kia Netherlands 13 27 0.1× 57 0.2× 441 1.6× 51 0.7× 42 0.8× 18 680
Manuèle Miné France 17 150 0.5× 29 0.1× 362 1.3× 7 0.1× 36 0.6× 27 612

Countries citing papers authored by Scott Heller

Since Specialization
Citations

This map shows the geographic impact of Scott Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Heller more than expected).

Fields of papers citing papers by Scott Heller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Heller. The network helps show where Scott Heller may publish in the future.

Co-authorship network of co-authors of Scott Heller

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Heller. A scholar is included among the top collaborators of Scott Heller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Heller. Scott Heller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Bush, Tammy L., Marc Payton, Scott Heller, et al.. (2013). AMG 900, a Small-Molecule Inhibitor of Aurora Kinases, Potentiates the Activity of Microtubule-Targeting Agents in Human Metastatic Breast Cancer Models. Molecular Cancer Therapeutics. 12(11). 2356–2366. 44 indexed citations
2.
Ajroud‐Driss, Senda, et al.. (2013). Prevalence and characteristics of pain in early and late stages of ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14(5-6). 369–372. 44 indexed citations
3.
Allen, Jeffrey A., Richard J. Chen, Senda Ajroud‐Driss, et al.. (2013). Gastrostomy tube placement by endoscopy versus radiologic methods in patients with ALS: A retrospective study of complications and outcome. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14(4). 308–314. 53 indexed citations
4.
Harrington, Paul E., Matthew P. Bourbeau, Christopher Fotsch, et al.. (2013). The optimization of aminooxadiazoles as orally active inhibitors of Cdc7. Bioorganic & Medicinal Chemistry Letters. 23(23). 6396–6400. 14 indexed citations
5.
Deng, Han‐Xiang, Hong Zhai, Eileen H. Bigio, et al.. (2010). FUS‐immunoreactive inclusions are a common feature in sporadic and non‐SOD1 familial amyotrophic lateral sclerosis. Annals of Neurology. 67(6). 739–748. 264 indexed citations
6.
Ajroud‐Driss, Senda, Mohammad Saeed, Humaira Majeed Khan, et al.. (2007). Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS. Amyotrophic Lateral Sclerosis. 8(5). 305–309. 13 indexed citations
7.
Remacle-Bonnet, M, Françoise Garrouste, Scott Heller, et al.. (2000). Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.. PubMed. 60(7). 2007–17. 127 indexed citations
8.
Mentzer, W C, et al.. (1994). Availability of related donors for bone marrow transplantation in sickle cell anemia.. PubMed. 16(1). 27–9. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026